Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity

Regulatory Peptides

Volumn 75-76, Issue , 1998, Pages 207-213

  Nie, Mei ^a   Selbie, Lisa A ^a  

^a Medical School   (United Kingdom)

Author keywords

Neuropeptide Y1 receptors; Neuropeptide Y2 receptors; PD09859; Peptide YY; Phosphatidylinositol 3 kinase; Wortmannin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PEPTIDE YY; RECEPTOR SUBTYPE; WORTMANNIN; ANDROSTANE DERIVATIVE; BORDETELLA VIRULENCE FACTOR; ENZYME INHIBITOR; FLAVONOID; NEUROPEPTIDE Y Y1 RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CHO CELL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAMSTER; HUMAN; METABOLISM; MUSCLE DEVELOPMENT; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CHO CELLS; CRICETINAE; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; MUSCLE DEVELOPMENT; MUSCLE, SMOOTH, VASCULAR; NEUROPEPTIDE Y; PEPTIDE YY; PERTUSSIS TOXIN; RECEPTORS, NEUROPEPTIDE Y; RECOMBINANT PROTEINS; TRANSFECTION; VIRULENCE FACTORS, BORDETELLA;

EID: 0032566428     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00070-6     Document Type: Article

References (38)

1. Edvinsson L., Hakanson R., Wahlestedt C., Uddman R. Effects of neuropeptide Y in the cardiovascular system. Trends in Pharmacological Sciences. 88:1987;231-235.
2. Waeber B., Aubert J., Corder R., Evequoz D., Nussberger J., Gaillard R., Brunner H.R. Am. J Hypertens. 1:1988;193-199.
3. Edvinsson L., Ekbald E., Hakanson R., Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br. J. Pharmacol. 83:1984;519-525.
4. Wahlestedt C, Hakanson R, Vaz CA, Zukowska-Grojec Z. Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am Physiol Soc 1990:R376-R742.
5. Erlinge D., Brunkwall J., Edvinsson L. Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells - cooperation with noradrenaline and ATP. Regul Peptides. 50:1994;259-265.
6. Zukowksa-Grojec Z., Pruszczyk P., Colton C., Yao J., Shen G.H., Myers A.K., Wahlestedt C. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides. 14:1993;263-268.
7. Shigeri Y., Fujimoto M. Neuropeptide Y stimulates DNA-synthesis in vascular smooth muscle cells. Neurosci Lett. 49:1993;19-22.
8. Millar B.C., Schluter K.D., Zhou X.J., McDermott B.J., Piper H.M. Neuropeptide Y stimulates hypertrophy of adult ventricuar cardiomyocytes. Am. J. Physiol. 266:1994;C1271-C1277.
9. Blomqvist A.G., Herzog H. Y-receptor subtypes - How many more? Trends in Neuroscience. 20:1997;294-298.
10. Gilman A.G. G-protein-transducers of receptor-generated signals. Annu. Rev. Biochem. 56:1987;615-649.
11. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. USA. 89:1992;5794-5798.
12. 1b-adrenergic receptors in the regulation of phospholipase C, protein kinase C and arachidonic acid production. J. Biol. Chem. 270:1995;11789-11796.
13. Larhammar D., Blomqvist A.G., Yee F., Jazin E., Yoo H.Y., Wahlestedt C. Cloning and funcitonal expresion of a human neuropeptide Y/peptide YY receptor of the Y1-type. J. Biol. Chem. 267:1992;10935-10938.
14. Rose P.M., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K., Kienzle B., Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem. 270:1995;22661-22664.
15. q-coupled receptor-mediated increases in cytosolic calcium. Regul Peptides. 71(3):1997;P13.
16. Selbie L.A., Hill S.J. G protein-coupled receptor cross-talk: the fine tuning of multiple receptor signalling pathways. Trends in Pharmacological Sciences. 19:1998;87-93.
17. Somlyo A.P., Somlyo A.V. Signal transduction and regulation of smooth muscle. Nature. 372:1994;231-236.
18. Kitazwa T., Masuo M., Somlyo A.P. G protein-mediated inhibition of myosin light chain phosphatase in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA. 88:1991;9307-9310.
19. Schlessinger J, Ullrich A. Growth factor signalling by receptor kinases. Neuron 1992:383-391.
20. van Biesen T., Luttrell L.M., Hawes B.E., Lefkowitz R.J. Mitogenic signalling via G protein-coupled receptors. Endocr Rev. 17:1996;698-714.
21. q-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 270:1995;7148-17153.
22. Koch B.E., van Biesen T., Koch W.J., Luttrell L.M., Lefkowitz R.J. Activation of the ras/mitogen activated protein-kinase signaling pathway by beta/gamma subunit of G-proteins utilizes a tyrosine kinase and is independent of phosphoinositide hydrolysis. Proc. Natl. Acad. Sci. USA. 91:1994;12706-12710.
23. i/o-coupled receptors. Biochem J. 328:1997;153-158.
24. Cicirelli M.F., Pelech S.L., Krebs E.G. Activation of multiple protein kinases during the burst in protein phosphorylation that precedes the first meiotic cell division in Xenopus oocytes. J. Biol. Chem. 263:1988;2009-2019.
25. Haycock J.W., Ahn N.G., Cobb M.H., Krebs E.G. ERK1 and ERK2, 2 microtubule-associated protein-2 kinases mediate the phosphorylation of tyrosine hydroxylase. Proc. Natl. Acad. Sci. USA. 89:1992;2365-2369.
26. Plevin R., Scott P.H., Robinson C.J., Gould G.W. Efficacy of agonist-stimulated MEK activation determines the susceptibility of mitogen-activated protein (MAP) kinase to inhibition in rat aortic smooth muscle cells. Biochem. J. 318:1996;657-663.
27. Nakamura M., Sakanaka C., Aoki Y., Ogasawara H., Tsuji T., Kodama X., Matsumoto T., Shimizu T., Noma M. Identification of 2 isoforms of mouse neuropeptide Y-Y1 receptors generated by alternative splicing-isolation, genomic structure, and functional expression of the receptors. J. Biol. Chem. 270:1995;30102-30110.
28. Rozengurt E. Neuropeptides as cellular growth factors: role of multiple signalling pathways. Eur. J. Clin. Invest. 21:1991;123-134.
29. Faure M., Voyno-Yasenetskaya T.A., Bourne H.R. cAMP and beta/gamma subunits of heterotrimeric G proteins stimulate mitogen-activated protein kinase in COS-7 cells. J. Biol. Chem. 269:1994;7851-7854.
30. Hawes B.E., Luttrell L.M., van Biesen T., Lefkowitz R.J. Phosphatidylinositol 3-kinase is an early intermediate in the G beta-gamma-mediated mitogen-activated protein kinase signalling pathway. J. Biol. Chem. 271:1996;12133-12136.
31. Della Rocca G.J., van Biesen T., Daaka Y., Luttrell D.K., Luttrell L.M., Lefkowitz R.J. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. J. Biol. Chem. 272:1997;19125-19132.
32. Dikic I., Tokiwa G., Lev S., Courtneidge S.A., Schlessinger J. A role for Pyk2 and Src in linking G protein-coupled receptors to MAPK kinase activation. Science. 383:1996;547-550.
33. Baltensperger K., Karoor V., Paul H., Ruoho A., Czech M.P., Malbon C. The β-adrenergic receptor is a substrate for the insulin receptor tyrosine kinase. J. Biol. Chem. 271:1996;1060-1064.
34. Jong Y.J., Dalemar L.R., Wilhelm B., Baenziger N.L. Human bradykinin-B(2) receptors isolated by receptor-specific monoclonal antibodies are tyrosine phosphorylated. Proc. Natl. Acad. Sci. USA. 90:1993;10994-10998.
35. Paxton W.G., Marrero M.B., Klein J.D., Delefontaine P., Berk B.C., Berstein K.E. The angiotensin II AT(1) receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases. Biochem. Biophys. Res. Commun. 200:1994;260-267.
36. 34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors. Peptides. 18:1997;397-401.
37. Zukowska-Grojec Z. Neuropeptide Y: New actions and implications for pathogenesis and treatment of cardiovascular and non-cardiovascular diseases. Regul Peptides 1997;17(3):18.
38. Allen B.G., Walsh M.P. The biochemical basis of the regulation of smooth-muscle contraction. Trends in Biological Science. 19:1994;362-368.